Abstract
The in vitro activity of azthreonam, a novel monocyclic beta-lactam antibiotic, was investigated for Gram negative urinary pathogens by determining the susceptibilities of 105 consecutive isolates from specimens submitted to the Auckland Hospital microbiology laboratory. All were sensitive or of intermediate sensitivity by disc diffusion testing. Minimum inhibitory concentrations (MICs) were 0.25 mg/l for 97 per cent of Enterobacteriaceae and ranged from 2-16 mg/l for Pseudomonas aeruginosa. Of antibiotics tested routinely in this laboratory only tobramycin showed comparable potency.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
